FKBP4 and allergic asthma: There is some suggestion in our data the increased FKBP51 may be more pronounced among regulatory T cells (Supplementary Figure S5); in a separate study intratracheal administration of regulatory T cells has been shown to reduce airway inflammation and hyperresponsiveness when administered in a murine allergic asthma model (33).